634 glycosylated proteins (Vector Laboratories)
Structured Review
634 Glycosylated Proteins, supplied by Vector Laboratories, used in various techniques. Bioz Stars score: 94/100, based on 48 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/AL-1233-2/Agarose+bound+Vicia+Villosa+Lectin+(VVL%2C+VVA)/pm42024456-297-8-16
Average 94 stars, based on 48 article reviews
Images
Related Articles
Incubation:Article Title: GALNT6 dual regulates innate immunity STING signaling and PD-L1 expression to promote immune evasion in pancreatic ductal adenocarcinoma. Article Snippet: Despite significant advancements in immunotherapy for cancer treatment, its effectiveness in pancreatic ductal adenocarcinoma (PDAC) remains disappointing, which is greatly due to the unique immunosuppressive microenvironment of PDAC.. Here, we focus on the involvement of GALNT6 in immune evasion mechanisms in PDAC.. Our results reveal a negative relationship between GALNT6 expression and immune cell infiltration in PDAC. Article Title: Targeting GALNT4 suppresses atherosclerosis via TNFR1/NF-κB mediated attenuation of endothelial inflammation. Article Snippet: Endothelial inflammation is a critical driver of atherosclerosis (AS).. Although N-acetylgalactosaminyltransferase 4 (GALNT4) has been genetically linked to coronary artery disease, its specific function and mechanism within endothelial cells (ECs) during AS progression remain poorly understood, presenting a significant knowledge gap.. This study aimed to elucidate the precise role of GALNT4 in endothelial inflammation and AS development. Article Title: A class of COPI adaptors regulates processing of transmembrane receptors by reinforcing their Golgi retention Article Snippet: .. WT or DKO lysates were incubated with Western Blot:Article Title: GALNT6 dual regulates innate immunity STING signaling and PD-L1 expression to promote immune evasion in pancreatic ductal adenocarcinoma. Article Snippet: Despite significant advancements in immunotherapy for cancer treatment, its effectiveness in pancreatic ductal adenocarcinoma (PDAC) remains disappointing, which is greatly due to the unique immunosuppressive microenvironment of PDAC.. Here, we focus on the involvement of GALNT6 in immune evasion mechanisms in PDAC.. Our results reveal a negative relationship between GALNT6 expression and immune cell infiltration in PDAC. Pull Down Assay:Article Title: GALNT4 controls aortic dissection by regulating vascular smooth muscle cell phenotype switch and dysfunction through the TGF-β/smad signaling. Article Snippet: Aortic dissection (AD) is a life-threatening vascular disorder whose underlying molecular mechanisms remain poorly understood.. Polypeptide N-acetylgalactosaminyltransferase 4 (GALNT4), an enzyme that transfers Nacetylgalactosamine (GalNAc) to serine and threonine residues on target proteins, has been implicated in the development of cardiovascular diseases.. However, its specific role in AD remains unclear. Concentration Assay:Article Title: GALNT4 controls aortic dissection by regulating vascular smooth muscle cell phenotype switch and dysfunction through the TGF-β/smad signaling. Article Snippet: Aortic dissection (AD) is a life-threatening vascular disorder whose underlying molecular mechanisms remain poorly understood.. Polypeptide N-acetylgalactosaminyltransferase 4 (GALNT4), an enzyme that transfers Nacetylgalactosamine (GalNAc) to serine and threonine residues on target proteins, has been implicated in the development of cardiovascular diseases.. However, its specific role in AD remains unclear. Immunoprecipitation:Article Title: GALNT4 controls aortic dissection by regulating vascular smooth muscle cell phenotype switch and dysfunction through the TGF-β/smad signaling. Article Snippet: Aortic dissection (AD) is a life-threatening vascular disorder whose underlying molecular mechanisms remain poorly understood.. Polypeptide N-acetylgalactosaminyltransferase 4 (GALNT4), an enzyme that transfers Nacetylgalactosamine (GalNAc) to serine and threonine residues on target proteins, has been implicated in the development of cardiovascular diseases.. However, its specific role in AD remains unclear. |
